A research collaboration led by the Hudson Institute of Medical Research as been awarded a $2.2-million grant to advance knowledge about ovarian granulosa cell tumors (GCT) and ultimately improve the outcomes of patients with this rare form of ovarian cancer. The multi-faceted research project will focus on mapping genetic mutations in GCTs, as well as developing better testing, finding gaps in patient data and care, and investigating personalized and combination treatment options. The five-year grant…
You must be logged in to read/download the full post.
The post $2.2M Awarded to Collaboration Researching Rare Form of Ovarian Cancer appeared first on BioNewsFeeds.